Key Dates

Related Announcements

PAR-22-161 - Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)

PAR-22-162 - Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute’s (NCI) Division of Cancer Control and Population Sciences (DCCPS) invites applications from investigators for cancer epidemiology cohorts through two recently published Funding Opportunity Announcements (FOAs). NCI will hold one pre-application webinar covering the two FOAs:

• PAR-22-161: This FOA seeks to support initiating and building new population-based cancer epidemiology cohorts to address specific knowledge gaps in cancer etiology and survivorship. Responsive should address critical scientific gaps concerning (i) new or unique exposures in relation to cancer risks and outcomes and/or (ii) achievement of diverse populations in cohorts with the inclusion of understudied populations (e.g., racial/ethnic groups, rural populations, individuals living in persistent poverty areas, and/or others) with substantial community engagement.
• PAR-22-162: Through this FOA, NCI encourages grant applications to support research in established cancer epidemiology cohort studies. Established studies are defined as those that have achieved their initial planned recruitment goal. Applications must include hypothesis-based research questions using data from an established cohort study and are expected to include related support for cohort maintenance and administration to address research across the cancer control continuum.

The pre-application webinar, to be held on April 27th, from 1:00 pm - 2:00 pm EDT, will include an overview of each funding opportunity and specific requirements for each. The webinar will conclude with a final, open question and answer session. This webinar will be recorded for anyone not able to make the live event and made available approximately two weeks following the live event on https://epi.grants.cancer.gov/cohorts/.

Registration for the webinar is required. Register and learn more here.

Please contact your program officer or the scientific contacts listed on the funding opportunities if you would like additional information.

• PAR-22-161, Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed).
  • Contact: Tram Kim Lam, PhD, MPH (lam[email protected])
• PAR-22-162, Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed).
  • Contact: Joanne Elena, PhD, MPH ([email protected])

Please visit the Division of Cancer Control and Population Sciences website for a comprehensive list of open funding opportunities.

Inquiries

Please direct all inquiries to:

Tram Kim Lam, PhD, MPH
National Cancer Institute (NCI)
Telephone: 240-276-6970
Email: [email protected]

Joanne Elena, PhD, MPH
National Cancer Institute (NCI)
Telephone: 240-276-6818
Email: [email protected]